Holen Sie sich die Stockscreener-App
1.50
5.66%
-0.09
Schlusskurs vom Vortag:
$1.59
Offen:
$1.59
24-Stunden-Volumen:
39,347
Relative Volume:
0.03
Marktkapitalisierung:
$72.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.33M
KGV:
-4.0399
EPS:
-0.3713
Netto-Cashflow:
$-8.02M
1W Leistung:
-12.79%
1M Leistung:
-9.09%
6M Leistung:
+5.63%
1J Leistung:
-61.54%
1-Tages-Spanne:
$1.48
$1.59
1-Wochen-Bereich:
$1.48
$1.7495
52-Wochen-Spanne:
$0.55
$10.00
Genenta Science Spa Adr Stock (GNTA) Company Profile
Firmenname
Genenta Science Spa Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare GNTA vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
1.50 | 72.33M | 0 | -7.33M | -8.02M | -0.3713 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-06-29 | Fortgesetzt | ROTH MKM | Buy |
| 2022-07-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-13 | Eingeleitet | Maxim Group | Buy |
Genenta Science Spa Adr Aktie (GNTA) Neueste Nachrichten
Genenta Science Confirms New Board, Share Buyback and Closes Sòphia High Tech Deal - TipRanks
GENENTA SCIENCE SPAADR (GNTA) Stock Chart - ChartMill
Enterprise value to EBITDA forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to EBIT forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to revenue forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Price to earnings forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands - The Globe and Mail
Genenta Science SpA Sponsored ADR Actuals & Estimates (NASDAQ:GNTA) - TradingView
Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026 - The Globe and Mail
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split - The Globe and Mail
Genenta Science Regains Compliance with Nasdaq Minimum Bid Price Rule - The Globe and Mail
Genenta Science regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com Australia
Genenta Science regains compliance with Nasdaq minimum bid price rule - Investing.com
Genenta sale al 100% della brianzola Atc (fucili per le forze speciali) e nomina il generale Luca Goretti nel cda - Milano Finanza
Unusual volume stocks in Tuesday's session - ChartMill
Which stocks have an unusual volume on Monday? - ChartMill
Which stocks are moving on Monday? - ChartMill
Monday's session: gap up and gap down stocks - ChartMill
Wondering what's happening in today's pre-market session? - ChartMill
Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C. - The Globe and Mail
GNTAGenenta Science SpA ADR Options - Finviz
On Friday, there are stocks with unusual volume. Let's take a look. - ChartMill
Wondering what's happening in today's after-hours session? - ChartMill
GNTA Stock Price, Quote & Chart | GENENTA SCIENCE SPAADR (NASDAQ:GNTA) - ChartMill
Genenta Science Ends Ospedale San Raffaele License to Refocus Strategy - TipRanks
Genenta Science to Close U.S. Subsidiary and Shift CFO to Consulting Role - The Globe and Mail
Genenta Science to close US subsidiary and transition CFO to consulting role - Investing.com Canada
Genenta Science to close US subsidiary and transition CFO to consulting role By Investing.com - Investing.com South Africa
Unusual VolumeStock ScreenerNews - Finviz
Genenta Science Moves Into Aerospace With Majority Investment Deal for Sòphia High Tech - The Globe and Mail
Genenta signs Definitive Agreements with Sophia High Tech - GlobeNewswire Inc.
Genenta Science Warned by Nasdaq Over Minimum Bid Price Compliance - The Globe and Mail
Genenta Science receives Nasdaq notice on minimum bid price compliance By Investing.com - Investing.com India
Genenta Science receives Nasdaq notice on minimum bid price compliance - Investing.com
What's going on in today's pre-market session - chartmill.com
Genenta Moves to Acquire Control of Italian Space-Defense Supplier Sòphia High Tech - TipRanks
Genenta Science Cancels Late-March Vote on Rebrand to Saentra Forge - The Globe and Mail
Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Acurx Pharmaceuticals (ACXP) - The Globe and Mail
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
Finanzdaten der Genenta Science Spa Adr-Aktie (GNTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):